Document is current
Any future updates will be listed below
-
Authors
Takazono, Takahiro https://orcid.org/0000-0002-0696-5386
Saito, Yoshiyuki https://orcid.org/0000-0002-8226-9219
Tashiro, Masato https://orcid.org/0000-0001-7609-7679
Yoshida, Masataka https://orcid.org/0009-0001-2955-6825
Takeda, Kazuaki https://orcid.org/0000-0003-1611-4435
Ide, Shotaro https://orcid.org/0000-0001-7872-8147
Iwanaga, Naoki https://orcid.org/0000-0002-0680-390X
Hosogaya, Naoki https://orcid.org/0000-0002-3229-2277
Sakamoto, Noriho https://orcid.org/0000-0002-7577-476X
Mukae, Hiroshi https://orcid.org/0000-0002-1429-5706
Izumikawa, Koichi https://orcid.org/0000-0001-9969-824X
-
Funding
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 4 December 2024
First Online: 26 December 2024
Declarations
:
: Y. Saito is an employee of Datack, Inc. and has indirectly received consulting fees through Datack, Inc. from Asahi Kasei Pharma Corporation. The other authors (Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Naoki Iwanaga, Naoki Hosogaya and Noriho Sakamoto) have no conflicts of interest to declare. T. Takazono, M. Tashiro, H. Mukae, and K. Izumikawa have received lecture fees from Asahi Kasei Pharma Corporation.
: The Ethics Committee of the Graduate School of Biomedical Sciences, Nagasaki University, approved the study protocol (protocol no.23072802).
